CD8A and infection: In sum, targeting of HCV-specific CD8+ T cell epitopes that have similar characteristics as the immunodominant epitopes restricted by the HLA class I types that protect from viral persistence in the natural course of infection might be an important goal for prophylactic HCV vaccines.